* Zepp Health Corp ZEPP.N ZEPP.K is expected to show a
rise in
quarterly revenue when it reports results on May 23.
* The Hefei Anhui-based company is expected to report a
13.8% increase in revenue to CNY861.597 million from CNY757.05
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. The company's guidance on March 21
2023, for the period ended March 31, was for revenue between
CNY600.00 million and CNY750.00 million.
* Refinitiv's mean analyst estimate for Zepp Health Corp is
for a
loss of 17 fen per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the phones &
handheld
devices peer group is also "Buy".
* Wall Street's median 12-month price target for Zepp Health
Corp
is $2.36, above its last closing price of $1.34.
This summary was machine generated May 19 at 12:34 GMT. All
figures in Chinese yuan renminbi unless otherwise stated